Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)-Reference-Cited by-同舟云学术

Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)

Published:2018-01 Issue:13 Volume:13 Page:1561-1564
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Chevalier Bernard,Cequier Angel,Dudek Dariusz,Haude Michael,Carrie Didier,Sabaté Manel,Windecker Stephan,Reith Sebastian,de Sousa Almeida Manuel,Campo Gianluca,Iñiguez Andres,Onuma Yoshi,Serruys Patrick

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Below-the-Knee Stents and Scaffolds: A Comprehensive Review;Seminars in Interventional Radiology;2023-04

2. Three‐year clinical outcomes of the novel sirolimus‐eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: A prospective patient‐level pooled analysis of NeoVas trials;Catheterization and Cardiovascular Interventions;2023-03-07

3. The standard versus prolonged dual antiplatelet therapy after the XINSORB bioresorbable scaffold implantation (SPARTA) trial: study protocol for a randomized controlled trial;Trials;2023-01-20

4. Third-Generation Sirolimus‐Eluting Bioresorbable Tyrocore Scaffold Implantation in Patients with ST‐Segment Elevation Myocardial Infarction: Baseline and 6-Month OCT and Clinical Outcomes—a FANTOM STEMI Pilot Study;Cardiovascular Drugs and Therapy;2023-01-14

5. Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials;Open Heart;2022-10